References
- Asgari, S., et al., 2016. Incidence and risk factors of isolated systolic and diastolic hypertension: a 10 year follow-up of the Tehran Lipids and Glucose Study. Blood pressure, 25 (3), 177–183.
- Askari, S., et al., 2014. Seasonal variations of blood pressure in adults: Tehran Lipid and Glucose Study. Archives of iranian medicine, 17 (6), 441–443.
- Assmann, T.S., et al., 2016. Nitric oxide levels in patients with diabetes mellitus: a systematic review and meta-analysis. Nitric oxide : biology and chemistry, 61, 1–9.
- Azizi, F., et al., 2009. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials, 10, 5.
- Azizi, F., et al., 2010. Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. Archives of Iranian medicine, 13 (5), 426–428.
- Alkuraishy, H.M., et al., 2017. Salivary nitrite in patients with type 2 diabetes mellitus: role of diabetic pharmacotherapy. Global journal of Pharmacy & pharmaceutical science, 1 (2), 1–5.
- Allen, J.D., et al., 2012. Nitrite and nitric oxide metabolism in peripheral artery disease. Nitric oxide : biology and chemistry, 26 (4), 217–222.
- American Diabetes Association. 2014. Standards of medical care in diabetes–2014. Diabetes care, 37 (Suppl 1), S14–S80.
- Bahadoran, Z., et al., 2015. Serum nitric oxide metabolites are associated with the risk of hypertriglyceridemic-waist phenotype in women: Tehran Lipid and Glucose Study. Nitric oxide : biology and chemistry, 50, 52–57.
- Bahadoran, Z., et al., 2016. Serum nitric oxide is associated with the risk of chronic kidney disease in women: Tehran lipid and glucose study. Scandinavian journal of clinical and laboratory investigation, 76 (4), 304–308.
- Baylis, C., et al., 1998. Measurement of nitrite and nitrate levels in plasma and urine-what does this measure tell us about the activity of the endogenous nitric oxide system? Current opinion in nephrology and hypertension, 7 (1), 59–62.
- Bedard, S., et al., 1997. Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase. The biochemical journal, 325 (Pt 2), 487–493.
- Behr-Roussel, D., et al., 2000. Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits. Circulation, 102 (9), 1033–1038.
- Caimi, G., et al., 2008. Nitric oxide metabolites (nitrite and nitrate) in young patients with recent acute myocardial infarction. Clinical hemorheology and microcirculation, 40 (2), 157–163.
- Caimi, G., et al., 2014. Nitric oxide metabolites (nitrite and nitrate) in several clinical condition. Clinical hemorheology and microcirculation, 56 (4), 359–369.
- Dallaire, P., et al., 2004. Obesity-linked insulin resistance: is nitric oxide the missing link. Canadian journal of diabetes, 28, 59–66.
- Derakhshan, A., et al., 2014. Sex specific incidence rates of type 2 diabetes and its risk factors over 9 years of follow-up: Tehran Lipid and Glucose Study. PLoS one, 9 (7), e102563.
- Feng, Q., et al., 2001. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation, 104 (6), 700–704.
- Ferlito, S., et al., 1999. Nitrite plasma levels in type 1 and 2 diabetics with and without complications. Minerva endocrinologica, 24 (3–4), 117–121.
- Förstermann, U., et al., 2012. Nitric oxide synthases: regulation and function. European heart Journal, 33 (7), 829–837.
- Ge, Y., et al., 2012. Identifying novel biomarkers for cardiovascular disease risk prediction. Journal of internal medicine, 272 (5), 430–439.
- Ghasemi, A., et al., 2007. Protein precipitation methods evaluated for determination of serum nitric oxide end products by the Griess assay. Journal of medical and surgical research, 2, 29–32.
- Ghasemi, A., et al., 2010b. Nitric oxide and clustering of metabolic syndrome components in pediatrics. European journal of epidemiology, 25 (1), 45–53.
- Ghasemi, A., et al., 2010a. Reference values for serum nitric oxide metabolites in an adult population. Clinical biochemistry, 43 (1–2), 89–94.
- Ghasemi, A., et al., 2011b. Association between serum nitric oxide metabolites and hypertension in a general population. International angiology : a journal of the International Union of Angiology, 30, 380–387.
- Ghasemi, A., et al., 2011a. Increased serum nitric oxide metabolites in dysglycaemia. Annals of human biology, 38 (5), 577–582.
- Ghasemi, A., et al., 2012. High serum nitric oxide metabolites and incident metabolic syndrome. Scandinavian journal of clinical and laboratory investigation, 72 (7), 523–530.
- Ghasemi, A., et al., 2013. Elevated nitric oxide metabolites are associated with obesity in women. Archives of Iranian medicine, 16 (9), 521–525.
- Ghasemi, A. and Zahediasl, S., 2011. Is nitric oxide a hormone? Iranian biomedical journal, 15 (3), 59–65.
- Ghasemi, A. and Zahediasl, S., 2012. Preanalytical and analytical considerations for measuring nitric oxide metabolites in serum or plasma using the Griess method. Clinical laboratory, 58 (7–8), 615–624.
- Gilchrist, M., et al., 2017. Inorganic nitrate: marker or mediator of mortality? Journal of the American Heart Association, 6 (11), e007782.
- Grundy, S.M., et al., 2005. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112 (17), 2735–2752.
- Gumanova, N.G., et al., 2017a. Serum nitrate and nitrite are associated with the prevalence of various chronic diseases except cancer. International angiology : a journal of the international union of angiology, 36 (2), 160–166.
- Gumanova, N.G., et al., 2017b. Serum nitrite and nitrate levels, NOx, can predict cardiovascular mortality in the elderly in a 3-year follow-up study. BioFactors (oxford, England), 43 (1), 82–89.
- Hadaegh, F., et al., 2016. Added value of total serum nitrate/nitrite for prediction of cardiovascular disease in middle east caucasian residents in Tehran. Nitric oxide : biology and chemistry, 54, 60–66.
- Higashi, Y., et al., 2001. Effect of obesity on endothelium-dependent, nitric oxide-mediated vasodilation in normotensive individuals and patients with essential hypertension. American journal of hypertension, 14 (10), 1038–1045.
- Higashino, H., et al., 2010. Serum nitric oxide metabolite levels in groups of patients with various diseases in comparison of healthy control subjects. Journal of medical sciences (Faisalabad), 10, 1–11.
- Hosmer, D. W., et al., 2005. Applied logistic regression. 2nd ed. Hobken, New Jersey: John Wiley & Sons, Inc.
- Investigators, A., 1989. The atherosclerosis risk in communit (aric) stui) y: design and objectwes. American journal of epidemiology, 129, 687–702.
- Lundberg, J.O., et al., 2004. Inorganic nitrate is a possible source for systemic generation of nitric oxide. Free radical biology & medicine, 37(3), 395–400.
- Lundberg, J.O., et al., 2005. NO generation from nitrite and its role in vascular control. Arteriosclerosis, thrombosis, and vascular biology, 25 (5), 915–922.
- Maas, R., et al., 2017. Plasma nitrate and incidence of cardiovascular disease and all-cause mortality in the community: the Framingham Offspring Study. Journal of the American Heart Association, 6. (11), e006224.
- Makhzani, P., et al., 2017. Are serum nitric oxide metabolites associated with fasting insulin among Iranian adults? (Tehran Lipid and Glucose Study). Endocrine research, 42 (2), 96–101.
- Mancia, G., et al., 2007. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension, 25, 1105–1187.
- Miranda, K.M., et al., 2001. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric oxide : biology and chemistry, 5 (1), 62–71.
- Momenan, A.A., et al., 2012. Reliability and validity of the Modifiable Activity Questionnaire (MAQ) in an Iranian urban adult population. Archives of Iranian medicine, 15, 279–282.
- Moshage, H., et al., 1995. Nitrite and nitrate determinations in plasma: a critical evaluation. Clinical chemistry, 41 (6 Pt 1), 892–896.
- Muhammed, S.J., et al., 2012. Pancreatic β-cell dysfunction, expression of iNOS and the effect of phosphodiesterase inhibitors in human pancreatic islets of type 2 diabetes. Diabetes, obesity & metabolism, 14 (11), 1010–1019.
- Murad, F., 1998. Nitric oxide signaling: would you believe that a simple free radical could be a second messenger, autacoid, paracrine substance, neurotransmitter, and hormone? Recent progress in hormone research, 53, 43–59. Discussion 59–60.
- Murad, F., 2004. Discovery of some of the biological effects of nitric oxide and its role in cell signaling. Bioscience reports, 24 (4–5), 452–474.
- Nathan, C., 1997. Inducible nitric oxide synthase: what difference does it make? The journal of clinical investigation, 100 (10), 2417–2423.
- Nikkari, S.T., et al., 2015. Functional inducible nitric oxide synthase gene variants associate with hypertension: a case–control study in a Finnish population—the TAMRISK Study. Medicine, 94 (46), e1958.
- Noronha, B.T., et al., 2005. Inducible nitric oxide synthase has divergent effects on vascular and metabolic function in obesity. Diabetes, 54 (4), 1082–1089.
- Ozcelik, O. and Algul, S., 2017. Nitric oxide levels in response to the patients with different stage of diabetes. Cellular and molecular biology (Noisy-le-grand), 63 (1), 49–52.
- Paoletti, R., et al., 2006. Metabolic syndrome, inflammation and atherosclerosis. Vascular health and risk management, 2 (2), 145–152.
- Perkins, N.J., et al., 2006. The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. American journal of epidemiology, 163 (7), 670–675.
- Pilon, G., et al., 2004. Inhibition of inducible nitric-oxide synthase by activators of AMP-activated protein kinase: a new mechanism of action of insulin-sensitizing drugs. The journal of biological chemistry, 279 (20), 20767–20774.
- Romitelli, F., et al., 2007. Comparison of nitrite/nitrate concentration in human plasma and serum samples measured by the enzymatic batch Griess assay, ion-pairing HPLC and ion-trap GC-MS: the importance of a correct removal of proteins in the Griess assay. Journal of chromatography. B, analytical technologies in the biomedical and life sciences, 851 (1–2), 257–267.
- Sardarinia, M., et al., 2016. Risk factors for incidence of cardiovascular diseases and all-cause mortality in a middle eastern population over a decade follow-up: Tehran Lipid and Glucose Study. PLoS ONE, 11 (12), e0167623.
- Soskić, S.S., et al., 2011. Regulation of inducible nitric oxide synthase (iNOS) and its Potential Role in Insulin Resistance, diabetes and heart failure. The open cardiovascular medicine journal, 5, 153–163.
- Stoclet, J.C., et al., 1998. Overproduction of nitric oxide in pathophysiology of blood vessels. Biochemistry. Biokhimiia, 63 (7), 826–832.
- Tsikas, D., 2005. Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids. Free radical research, 39 (8), 797–815.
- Tsikas, D., 2015. Circulating and excretory nitrite and nitrate: their value as measures of nitric oxide synthesis, bioavailability and activity is inherently limited. Nitric oxide : biology and chemistry, 45, 1–3.
- Watanabe, T., et al., 2000. Influence of sex and age on serum nitrite/nitrate concentration in healthy subjects. Clinica chimica acta, 301 (1–2), 169–179.
- White, E., et al., 1998. Exposure measurement in cohort studies: the challenges of prospective data collection. Epidemiologic reviews, 20 (1), 43–56.
- Yoon, Y., et al., 2000. Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clinical chemistry, 46 (10), 1626–1630.
- Zahedi Asl, S., et al., 2008. Serum nitric oxide metabolites in subjects with metabolic syndrome. Clinical biochemistry, 41 (16–17), 1342–1347.